Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.
Alfred L. Garfall, MD
Advertisement
Articles by Alfred L. Garfall, MD
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024.
Advertisement
Latest Updated Articles
ASCO 2024: DREAMM-8 Study of Belantamab Mafodotin, Pomalidomide, and DexamethasonePublished: July 19th 2024 | Updated:
- Future Directions in the Management of Multiple Myeloma
Published: July 24th 2024 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
2
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
3
FDA Grants Breakthrough Therapy Designation to R-DXd in CDH6-Expressing Ovarian Cancer
4
Science Under Attack: Experts Warn of Rising Threats to Research Integrity
5
